相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis due to Reactivation of Hepatitis B Virus in Endemic Areas Among Patients With Hepatitis C Treated With Direct-acting Antiviral Agents
Cheng Wang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
Teng-Yu Lee et al.
HEPATOLOGY (2016)
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
Joseph Ahn et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B
Hye Soo Kim et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan
Yen-Hsuan Ni et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk
Yen-Tsung Huang et al.
EPIDEMIOLOGY (2016)
Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression
Jessica Liu et al.
HEPATOLOGY (2016)
Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy
Yeon Seok Seo et al.
MEDICINE (2016)
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir
Jeffrey M. Collins et al.
CLINICAL INFECTIOUS DISEASES (2015)
Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan
Ching-Lan Cheng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Huge Gap Between Clinical Efficacy and Community Effectiveness in the Treatment of Chronic Hepatitis C A Nationwide Survey in Taiwan
Ming-Lung Yu et al.
MEDICINE (2015)
Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular Carcinoma
Yao-Chun Hsu et al.
SEMINARS IN ONCOLOGY (2015)
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
Pauline Arends et al.
GUT (2015)
Effect of Virological Response to Entecavir on the Development of Hepatocellular Carcinoma in Hepatitis B Viral Cirrhotic Patients: Comparison Between Compensated and Decompensated Cirrhosis
Soon Sun Kim et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality
Chun-Jen Liu et al.
GUT (2014)
On-Treatment Alpha-Fetoprotein Is a Specific Tumor Marker for Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Entecavir
Grace L. H. Wong et al.
HEPATOLOGY (2014)
Determinants of hepatocellular carcinoma in cirrhotic patients treated with nucleos(t)ide analogues for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence
Abby B. Siegel et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study
Yao-Chun Hsu et al.
HEPATOLOGY (2012)
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Long-term continuous entecavir therapy in nucleos(t)ide-naive chronic hepatitis B patients
Atsushi Ono et al.
JOURNAL OF HEPATOLOGY (2012)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
J. J. Y. Sung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Two decades of universal hepatitis B vaccination in Taiwan: Impact and implication for future strategies
Yen-Hsuan Ni et al.
GASTROENTEROLOGY (2007)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
分享论文
